Plasma progesterone, 17-hydroxyprogesterone, androstenedione and testosterone in prepubertal, pubertal and adult subjects with congenital virilizing adrenal hyperplasia as indicators of adrenal suppression
- PMID: 7196877
- DOI: 10.1159/000179303
Plasma progesterone, 17-hydroxyprogesterone, androstenedione and testosterone in prepubertal, pubertal and adult subjects with congenital virilizing adrenal hyperplasia as indicators of adrenal suppression
Abstract
To determine whether a single morning plasma level of 17-hydroxyprogesterone (17OH-P), androstenedione, testosterone and progesterone reflected the degree of control of 21-hydroxylase congenital virilizing adrenal hyperplasia (CVAH) as indicated by 24-hour urinary 17-ketosteroid and pregnanetriol excretion, 142 simultaneous 24-hour urine and morning blood collections were made from 65 patients with CVAH. Patients were grouped into five categories on the basis of age, skeletal age, and sex. Paired blood and urinary data were analyzed. The results suggest that androstenedione is the most reliable indicator for all patient categories. Testosterone is an excellent indicator for children of both sexes and for adolescent and adult females. Levels of 17OH-P are difficult to interpret, as they can be several fold higher than the normal values when adrenal suppression appears adequate on the basis of urinary data. In general, progesterone is a poor indicator.
Similar articles
-
The relationships between serum concentrations of 17OH-progesterone and other serum and urinary steroids in patients with congenital adrenal hyperplasia.J Clin Endocrinol Metab. 1978 Jan;46(1):98-104. doi: 10.1210/jcem-46-1-98. J Clin Endocrinol Metab. 1978. PMID: 752027
-
3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.J Clin Endocrinol Metab. 1991 Jul;73(1):166-74. doi: 10.1210/jcem-73-1-166. J Clin Endocrinol Metab. 1991. PMID: 2045467
-
Serum 17-alpha-hydroxyprogesterone, progesterone, estradiol, and testosterone in the diagnosis and management of congenital adrenal hyperplasia.J Pediatr. 1974 Dec;85(6):782-7. doi: 10.1016/s0022-3476(74)80340-9. J Pediatr. 1974. PMID: 4371221 No abstract available.
-
Monitoring of therapy in congenital adrenal hyperplasia.Clin Chem. 2010 Aug;56(8):1245-51. doi: 10.1373/clinchem.2010.146035. Epub 2010 Jun 17. Clin Chem. 2010. PMID: 20558634 Review.
-
[Common and uncommon forms of female sexual precocity and their biological diagnosis].Ann Pediatr (Paris). 1984 Mar;31(3):183-92. Ann Pediatr (Paris). 1984. PMID: 6232887 Review. French. No abstract available.
Cited by
-
Nocturnal Dexamethasone versus Hydrocortisone for the Treatment of Children with Congenital Adrenal Hyperplasia.Int J Pediatr Endocrinol. 2010;2010:347636. doi: 10.1155/2010/347636. Epub 2010 Sep 14. Int J Pediatr Endocrinol. 2010. PMID: 20871859 Free PMC article.
-
Duration of suppression of adrenal steroids after glucocorticoid administration.Int J Pediatr Endocrinol. 2010;2010:712549. doi: 10.1155/2010/712549. Epub 2010 Mar 31. Int J Pediatr Endocrinol. 2010. PMID: 20379352 Free PMC article.
-
Salivary Profiles of 11-oxygenated Androgens Follow a Diurnal Rhythm in Patients With Congenital Adrenal Hyperplasia.J Clin Endocrinol Metab. 2021 Oct 21;106(11):e4509-e4519. doi: 10.1210/clinem/dgab446. J Clin Endocrinol Metab. 2021. PMID: 34165575 Free PMC article.
-
Management of 21-hydroxylase deficiency congenital adrenal hyperplasia: A survey of Canadian paediatric endocrinologists.Paediatr Child Health. 2005 Jul;10(6):323-6. Paediatr Child Health. 2005. PMID: 19675839 Free PMC article.
-
Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia.Horm Res Paediatr. 2011;75(1):19-25. doi: 10.1159/000315910. Epub 2010 Aug 25. Horm Res Paediatr. 2011. PMID: 20798478 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical